Nexgel Historical Income Statement
| NXGL Stock | USD 3.37 0.05 1.51% |
Historical analysis of Nexgel income statement accounts such as Other Operating Expenses of 4.6 M can show how well Nexgel Inc performed in making a profits. Evaluating Nexgel income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nexgel's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Nexgel Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nexgel Inc is a good buy for the upcoming year.
Nexgel |
About Nexgel Income Statement Analysis
Nexgel Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nexgel shareholders. The income statement also shows Nexgel investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Nexgel Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Nexgel Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nexgel Inc. It is also known as Nexgel overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Nexgel Inc income statement and represents the costs associated with goods and services Nexgel provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Nexgel's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nexgel Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Nexgel's Gross Profit is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 303.4 K this year, although the value of Total Revenue will most likely fall to about 2.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 1.6M | 2.0M | 4.1M | 2.1M | Depreciation And Amortization | 113K | 301K | 443K | 266.2K |
Nexgel income statement Correlations
Click cells to compare fundamentals
Nexgel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nexgel income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 67K | 50K | 113K | 301K | 443K | 266.2K | |
| Total Revenue | 717K | 674K | 1.6M | 2.0M | 4.1M | 2.1M | |
| Gross Profit | (137K) | (291K) | 9K | 256K | 619K | 650.0K | |
| Other Operating Expenses | 2.6M | 2.9M | 4.1M | 5.4M | 7.6M | 4.6M | |
| Operating Income | (1.9M) | (2.3M) | (2.6M) | (3.3M) | (3.5M) | (3.7M) | |
| Ebit | (1.9M) | (2.3M) | (2.3M) | (3.4M) | (3.2M) | (3.3M) | |
| Ebitda | (1.9M) | (2.2M) | (2.2M) | (3.1M) | (2.7M) | (2.9M) | |
| Cost Of Revenue | 854K | 965K | 1.5M | 1.8M | 3.5M | 2.0M | |
| Total Operating Expenses | 1.8M | 2.0M | 2.6M | 3.6M | 4.1M | 2.7M | |
| Income Before Tax | (1.9M) | (2.3M) | (4.3M) | (4.7M) | (3.2M) | (3.3M) | |
| Net Income | (1.9M) | (2.3M) | (6.3M) | (6.1M) | (3.2M) | (3.3M) | |
| Interest Expense | 1K | 10K | 2.0M | 1.3M | 15K | 14.3K | |
| Net Income Applicable To Common Shares | (1.9M) | (2.3M) | (4.3M) | (4.7M) | (4.3M) | (4.5M) | |
| Selling General Administrative | 1.8M | 2.0M | 2.5M | 2.4M | 3.0M | 2.6M | |
| Net Income From Continuing Ops | (1.9M) | (2.3M) | (4.3M) | (4.7M) | (2.6M) | (2.8M) | |
| Reconciled Depreciation | 67K | 50K | 113K | 301K | 320K | 215.1K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 0.846 | Quarterly Revenue Growth 0.234 | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.